Treatment of severe oligospermia with human chorionic gonadotropin/human menopausal gonadotropin: a placebo-controlled, double blind trial
- PMID: 3119647
- DOI: 10.1210/jcem-65-6-1081
Treatment of severe oligospermia with human chorionic gonadotropin/human menopausal gonadotropin: a placebo-controlled, double blind trial
Abstract
In an effort to evaluate the effect of hCG/human menopausal gonadotropin (hMG) treatment on semen parameters in normogonadotropic men suffering from oligospermia, a double blind, placebo-controlled study was conducted. After 2 basal examinations of seminal parameters and reproductive hormones, 39 men were recruited for the trial. Nineteen men, allocated randomly to the active drug group, received im injections of 2500 IU hCG twice a week in combination with 150 IU hMG three times a week for 13 weeks, while 20 men were treated, following the same injection schedule, with NaCl only. After the 13-week treatment period, follow-up examination was performed, followed by 3 additional examinations at 4-week intervals. Of those men receiving hCG-hMG, 2 induced pregnancies in their wives, while no pregnancies were reported in the placebo group. Sperm concentrations, the percentages of motile sperm, and the proportions of normally formed spermatozoa, however, were similar in the 2 groups at all times. It was not possible to predict the outcome of treatment based on results of GnRH and hCG tests performed before the treatment phase.
Similar articles
-
[Treatment of oligozoospermia with HMG and HCG in normogonadotropic men].Hautarzt. 1977 Sep;28(9):478-80. Hautarzt. 1977. PMID: 914517 German.
-
Two-year comparison of testicular responses to pulsatile gonadotropin-releasing hormone and exogenous gonadotropins from the inception of therapy in men with isolated hypogonadotropic hypogonadism.J Clin Endocrinol Metab. 1988 Dec;67(6):1140-5. doi: 10.1210/jcem-67-6-1140. J Clin Endocrinol Metab. 1988. PMID: 3142911
-
Optimization of spermatogenesis-regulating hormones in patients with non-obstructive azoospermia and its impact on sperm retrieval: a multicentre study.BJU Int. 2013 Mar;111(3 Pt B):E110-4. doi: 10.1111/j.1464-410X.2012.11485.x. Epub 2012 Sep 7. BJU Int. 2013. PMID: 22958644
-
A modern approach to the gonadotropin treatment in oligozoospermia.Andrologia. 1981 May-Jun;13(3):187-97. doi: 10.1111/j.1439-0272.1981.tb00030.x. Andrologia. 1981. PMID: 6791520 Review.
-
Immunomodulatory and Kidney-Protective Effects of the Human Chorionic Gonadotropin Derivate EA-230.Nephron. 2018;140(2):148-151. doi: 10.1159/000490772. Epub 2018 Jul 6. Nephron. 2018. PMID: 29982253 Free PMC article. Review.
Cited by
-
[Testosterone and infertility].Urologe A. 2010 Jan;49(1):32-6. doi: 10.1007/s00120-009-2195-x. Urologe A. 2010. PMID: 20063086 German.
-
The use of follicle stimulating hormone (FSH) for the treatment of the infertile man: position statement from the Italian Society of Andrology and Sexual Medicine (SIAMS).J Endocrinol Invest. 2018 Sep;41(9):1107-1122. doi: 10.1007/s40618-018-0843-y. Epub 2018 Feb 1. J Endocrinol Invest. 2018. PMID: 29392544 No abstract available.
-
In vitro bioassays of follicle-stimulating hormone: methods and clinical applications.J Endocrinol Invest. 1991 Dec;14(11):983-97. doi: 10.1007/BF03347131. J Endocrinol Invest. 1991. PMID: 1806618 Review. No abstract available.
-
Clinical Use of FSH in Male Infertility.Front Endocrinol (Lausanne). 2019 May 24;10:322. doi: 10.3389/fendo.2019.00322. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 31178827 Free PMC article. Review.
-
FSH treatment of male idiopathic infertility improves pregnancy rate: a meta-analysis.Endocr Connect. 2015 Sep;4(3):R46-58. doi: 10.1530/EC-15-0050. Epub 2015 Jun 25. Endocr Connect. 2015. PMID: 26113521 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources